Company / Shares Outstanding
GT Biopharma, Inc. Shares Outstanding History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
4.1M
FY2020
5-year range
104.2K / 573.1M
FY2016-FY2020
Trend
+3838.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +3839% YoY in FY2020, a notable deviation from the 7-year average annual change of +546%.
Based on SEC 10-K filings.
4104982.00 in FY2020 with a 5-year CAGR of +11.6%.
Increased from 2400000.00 to 4104982.00 over the past 4 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +240.2%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, shares outstanding increased 3838.8% year-over-year.
- Peak shares outstanding was recorded in FY2014.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | 4.1M | +3838.8% |
| FY2017 | 104.2K | -95.7% |
| FY2016 | 2.4M | +1.4% |
| FY2015 | 2.4M | -99.6% |
| FY2014 | 573.1M | +14.5% |
| FY2013 | 500.6M | +85.9% |
| FY2012 | 269.3M | +80.0% |
| FY2011 | 149.6M | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026